GLOBUS MEDICAL INC (GMED)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net sales | 745,342 | 598,121 | 625,705 | 629,691 |
| Restructuring costs | 13,547 | - | 5,191 | -566 |
| Research and development | 39,954 | 33,062 | 35,380 | 37,698 |
| Cost of sales (exclusive of amortization of intangibles) | 248,765 | 195,397 | 270,515 | 260,040 |
| Acquisition-related costs | 33,156 | 1,057 | -3,617 | 13,734 |
| Amortization of intangibles | 30,189 | 28,802 | 30,076 | 29,709 |
| Selling, general and administrative | 303,622 | 242,799 | 240,738 | 238,119 |
| Litigation settlement, expense | - | - | -676 | 1,335 |
| Gross profit | - | - | - | 369,651 |
| Operating expenses | - | - | - | 320,029 |
| Operating income/(loss) | 76,109 | 97,004 | 48,098 | 49,622 |
| Other nonoperating income | - | - | - | 997 |
| Other income/(expense) | 772 | 713 | -570 | -2,041 |
| Interest income/(expense), net | 693 | 1,681 | -775 | -2,335 |
| Foreign currency transaction gain/(loss) | 38 | 4,270 | 10,279 | -703 |
| Bargain purchase gain | 110,561 | - | - | - |
| Total other income/(expense), net | 112,064 | 6,664 | 8,934 | - |
| Income/(loss) before income taxes | 188,173 | 103,668 | 57,032 | 47,581 |
| Income tax provision/(benefit) | -14,673 | 28,206 | 5,196 | 15,821 |
| Net income/(loss) | 202,846 | 75,462 | 51,836 | 31,760 |
| Unrealized gain/(loss) on marketable securities | 2 | 315 | 912 | 492 |
| Foreign currency translation gain/(loss) | 12,404 | 4,379 | 3,976 | -1,298 |
| Total other comprehensive income/(loss), net of tax | 12,406 | 4,694 | 4,888 | -806 |
| Comprehensive income/(loss) | 215,252 | 80,156 | 56,724 | 30,954 |
| Earnings per share, basic | 1.5 | 0.55 | 0.38 | 0.23 |
| Earnings per share, diluted | 1.49 | 0.54 | 0.38 | 0.23 |
| Weighted average number of shares outstanding, basic | 135,205,000 | 136,757,000 | 135,615,000 | 135,195,000 |
| Weighted average number of shares outstanding, diluted | 136,499,000 | 139,774,000 | 138,062,000 | 136,979,000 |